Compliance to clinical pathways in the management of suspected pulmonary embolus: are there cost implications?

Abstract

This study investigated the cost implications of poor compliance to established guidelines for management of suspected pulmonary embolism (PE) in two NSW public hospitals. A retrospective audit showed that the prevalence of PE overall was 9.9% (4.3% in the low-risk groups) in 436 patients. An estimated total of $32 454 (14%) was spent on unnecessary tests.

DOI: 10.1111/imj.13387

Cite this paper

@article{Rehman2017ComplianceTC, title={Compliance to clinical pathways in the management of suspected pulmonary embolus: are there cost implications?}, author={Ata Rehman and Eric Yelf and Jacqueline Pearson and Wilf W Yeo}, journal={Internal medicine journal}, year={2017}, volume={47 4}, pages={458-461} }